COSCIENS Comments on Unusual Market Activity

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire Article contentTORONTO, ONTARIO, April 07, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) is issuing this news release in response to unusual market activity. While the Company does not normally comment on market activity or market speculation, the Company confirms that it is not aware of any material undisclosed information relating to the Company that would account for the recent increase in trading activity in, and trading price of, the Company’s common shares.Sign In or Create an AccountEmail AddressContinueor View more offersArticle contentArticle contentAbout COSCIENS Biopharma Inc. Article contentWe apologize, but this video has failed to load.Try refreshing your browser, ortap here to see other videos from our team.Article contentTop StoriesGet the latest headlines, breaking news and columns.There was an error, please provide a valid email address.Sign UpBy signing up you consent to receive the above newsletter from Postmedia Network Inc.Thanks for signing up!A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try againInterested in more newsletters? Browse here.Article contentCOSCIENS is a life science company focused on the development of natural, plant-based active ingredients, leveraging the Company’s proprietary manufacturing and extraction technologies to develop Avenanthramides and Beta Glucan active ingredients currently used in leading skincare brands worldwide. The Company’s common shares are listed on the TSX under the symbol “CSCI” and are listed and posted for trading on the OTCQB® Venture Market under the symbol “CSCIF”. For more information, please visit COSCIENS’ website at www.cosciensbio.com.Article contentIssuer Contact:Peter H. Puccetti Interim CEO and Chairman of the Boardpp@cosciensbio.comArticle contentGiuliano La FrattaChief Financial Officerglafratta@cosciensbio.comArticle contentInvestor Contact:IR@cosciensbio.comArticle contentArticle contentArticle contentArticle contentArticle contentArticle contentTrending Doritos at US$7 a bag ended up costing PepsiCo billions Retail & Marketing Canadian pension plans are so healthy that employers are taking a contribution 'holiday,' says Mercer Retirement Canada's accountant shortage is starting to add up despite quieter tax season Personal Finance William Watson: Open the highway, you crazy New Brunswickers! FP Comment Microsoft vows data centres will not hike Canadians' water and electricity bills Innovation Share this article in your social networkCommentsYou must be logged in to join the discussion or read more comments.Create an AccountSign in Join the Conversation Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information. Doritos at US$7 a bag ended up costing PepsiCo billions Retail & Marketing Canadian pension plans are so healthy that employers are taking a contribution 'holiday,' says Mercer Retirement Canada's accountant shortage is starting to add up despite quieter tax season Personal Finance William Watson: Open the highway, you crazy New Brunswickers! FP Comment Microsoft vows data centres will not hike Canadians' water and electricity bills Innovation